SCHAUMBURG, Ill., Oct. 9 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, and Itochu Chemical Frontier Corporation (ICF), a privately-held global company in the field of pharmaceutical and organic and fine chemicals based in Japan, today announced finalization of a development and supply collaboration. Under the agreement, ICF will supply injectable products for which Sagent will obtain U.S. regulatory approval and market in the United States.
"We are extremely pleased to partner with a global company of Itochu's caliber and skills on these exciting product opportunities," said Jeffrey M. Yordon, CEO, founder and chairman of the board of Sagent Pharmaceuticals, Inc. "Sagent is committed to expanding its network of worldwide strategic partnerships to offer the most diverse and extensive pipeline of the highest quality injectable products to our hospital focused customers and we look forward to including ICF amongst our partners."
"ICF looks forward to rapidly expanding our presence in the U.S. market," said Jun Sato, ICF's president and chief executive officer. "We believe that this collaboration combining ICF's experience in the Japanese market with Sagent's U.S. focused injectable selling and marketing capabilities is an optimal path toward achieving this objective."
About Sagent Pharmaceuticals, Inc.
Sagent Pharmaceuticals, founded in 2006, is a privately held specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectable products. Sagent has created a unique, global network of resources, comprised of rapid development capabilities, sophisticated manufacturing and innovative drug-delivery technologies, quickly yielding an extensive portfolio of pharmaceutical products that fulfills the evolving needs of patients. Sagent currently has more than 200 products in development.
To Discover Injectables Excellence(TM) and learn more about Sagent, please visit http://www.SagentPharma.com.
About Itochu Chemical Frontier Corporation
Itochu Chemical Frontier Corporation (ICF) is the core enterprise of Pharmaceutical & Life-science and Organic & Fine Chemical field in ITOCHU Corporation which is one of the largest trading houses in the world. Pharmaceutical division of ICF has a global net work of resources for Active Pharmaceutical Ingredient (API) and Pharmaceutical Finished Products in the extensive pipeline from primary care to high potency pharmaceuticals such as antibiotic, anticancer and biologic products and supplies them to our worldwide business partners.
To learn more about Itochu Chemical Frontier, please visit http://www.itcchem.co.jp/en/index.html
CONTACT: Investors, Ronald Pauli of Sagent Pharmaceuticals, Inc.,
+1-847-908-1604; or Media, Geoff Curtis of WeissComm Partners,
+1-312-646-6298, for Sagent Pharmaceuticals, Inc.
Web site: http://www.SagentPharma.com/
http://www.itcchem.co.jp/en/index.html/
